Saturday, June 17, 2023 10:18:28 PM
Thanks for sharing the news.
I feel like LP is doing something more important than filing for approval too.
Here is the description about Dr. Bosch planned to present first showed up in the beginning of April.
But we didn't see the other three parts. Here are the comparisons about the same content between the present on March 15 and the one on June 3.
Clearly Dr. Bosch worked carefully page by page on his present. He even removed the shade of the frame in the new present. It is hard to believe that for a scientist as careful and as meticulous as he is, he would put the descriptions about his presentation back in April without careful planning. He must skip the three parts because of something important. I suspect we will know it soon.
I feel like LP is doing something more important than filing for approval too.
Here is the description about Dr. Bosch planned to present first showed up in the beginning of April.
The presentation focuses on action mechanisms, immune responses, combination therapies, imaging analyses & manufacturing considerations.
But we didn't see the other three parts. Here are the comparisons about the same content between the present on March 15 and the one on June 3.
Clearly Dr. Bosch worked carefully page by page on his present. He even removed the shade of the frame in the new present. It is hard to believe that for a scientist as careful and as meticulous as he is, he would put the descriptions about his presentation back in April without careful planning. He must skip the three parts because of something important. I suspect we will know it soon.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
